Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Assembly Biosciences (NQ: ASMB ) 14.73 +0.08 (+0.54%) Streaming Delayed Price Updated: 10:55 AM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Assembly Biosciences < Previous 1 2 3 4 Next > ASMB Stock Earnings: Assembly Biosciences Beats EPS, Beats Revenue for Q2 2024 August 09, 2024 ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates August 08, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop July 15, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire Insiders Buying American Software And 2 Other Stocks July 09, 2024 Via Benzinga Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection June 18, 2024 – Phase 1b study will evaluate safety, pharmacokinetic and efficacy endpoints in participants with chronic hepatitis B virus infection with interim data expected by the end of 2024 – From Assembly Biosciences, Inc. Via GlobeNewswire Assembly Biosciences Announces $12.6 Million in Equity Financings June 17, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366 June 10, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024 June 05, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024 May 22, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024 May 13, 2024 ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights May 08, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q4 2023 March 28, 2024 ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights March 28, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire ASMB Stock Earnings: Assembly Biosciences Misses EPS for Q2 2023 March 25, 2024 ASMB stock results show that Assembly Biosciences missed analyst estimates for earnings per share the second quarter of 2023. Via InvestorPlace Assembly Biosciences Announces Effective Date of Reverse Stock Split February 08, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire Assembly Biosciences Provides Anticipated Development Milestones for 2024 January 04, 2024 From Assembly Biosciences, Inc. Via GlobeNewswire Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket December 12, 2023 Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session November 24, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session November 23, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session November 22, 2023 Via Benzinga Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) November 10, 2023 From Assembly Biosciences, Inc. Via GlobeNewswire Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting® November 10, 2023 From Assembly Biosciences, Inc. Via GlobeNewswire Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates November 08, 2023 From Assembly Biosciences, Inc. Via GlobeNewswire Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer November 08, 2023 From Assembly Biosciences, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session October 25, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session October 18, 2023 Via Benzinga Crude Oil Moves Lower; Bank of America Profit Beats Expectations October 17, 2023 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 17, 2023 Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 17, 2023 Via Benzinga Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earnings October 17, 2023 U.S. stocks traded mostly higher midway through trading, with the Dow Jones falling gaining around 100 points on Tuesday. The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52.... Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.